Hazelden Betty Ford Foundation Presents Let's Talk Addiction and Recovery with William C. Moyers

Let's Talk Addiction & Recovery

Hazelden Betty Ford Foundation

  • What to Make of Ketamine: Dangerous Drug or Miracle Medicine?

What to Make of Ketamine: Dangerous Drug or Miracle Medicine?

Wednesday 4th May 2022

Explore ketamine's dual role as a rapid depression treatment and potential addiction risk with Dr. Marvin Seppala and William C. Moyers.
 

About this podcast

Let's Talk Addiction & Recovery
Author:
Hazelden Betty Ford Foundation Presents Let's Talk Addiction and Recovery with William C. Moyers
Overview:
Categories:
Innovative Treatments & Recovery Paths
Sobriety Toolkit
Family Recovery from Addiction
Creative Recovery Journeys
Empowering Recovery Journeys
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Ketamine: Miracle Cure or Risky Gamble?

Is ketamine a wonder drug or a dangerous addiction risk? This episode of 'Let's Talk Addiction & Recovery' dives into the complex world of ketamine, a drug known for its rapid relief of severe depression but also for its addictive potential. Host William C. Moyers sits down with former Chief Medical Officer Marvin Seppala, MD, to explore the dual nature of this controversial treatment.
They discuss how ketamine works on multiple brain receptor sites, its hallucinogenic effects, and the fine line between therapeutic use and addiction risk. Whether you're curious about new treatments for depression or concerned about the implications for those in recovery, this conversation sheds light on the promises and perils of ketamine.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.